A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.
We propose an integrative, mechanistic model that integrates in vitro virology data, pharmacokinetics, and viral response to a combination regimen of a direct-acting antiviral (telaprevir, an HCV NS3-4A protease inhibitor) and peginterferon alfa-2a/ribavirin (PR) in patients with genotype 1 chronic...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1ebc60fb8b8d4ddcaf1eafea5ed2727d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|